[1]
Koehn, F.E.; Carter, G.T. The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov., 2005, 4(3), 206-220.
[2]
Li, J.W.; Vederas, J.C. Drug discovery and natural products: end of an era or an endless frontier? Science, 2009, 325(5937), 161-165.
[3]
Belluti, F.; Fontana, G.; Dal Bo, L.; Carenini, N.; Giommarelli, C.; Zunino, F. Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents. Bioorg. Med. Chem., 2010, 18(10), 3543-3550.
[4]
Riveiro, M.E.; Moglioni, A.; Vazquez, R.; Gomez, N.; Facorro, G.; Piehl, L.; de Celis, E.R.; Shayo, C.; Davio, C. Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells. Bioorg. Med. Chem., 2008, (5), 2665-2675.
[5]
Roussaki, M.; Kontogiorgis, C.A.; Hadjipavlou-Litina, D.; Hamilakis, S.; Detsi, A. A novel synthesis of 3-aryl coumarins and evaluation of their antioxidant and lipoxygenase inhibitory activity. Bioorg. Med. Chem. Lett., 2010, 20(13), 3889-3892.
[6]
Tomohiro, N.; Yasuko, K.; Sei-Itsu, M. Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis. Biochim. Biophys. Acta, 1983, 753(1), 130-132.
[7]
Fylaktakidou, K.C.; Hadjipavlou-Litina, D.J.; Litinas, K.E.; Nicolaides, D.N. Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr. Pharm. Des., 2004, 10(30), 3813-3833.
[8]
Chimenti, F.; Bizzarri, B.; Bolasco, A.; Secci, D.; Chimenti, P.; Granese, A.; Carradori, S.; Rivanera, D.; Zicari, A.; Scaltrito, M.M.; Sisto, F. Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides. Bioorg. Med. Chem. Lett., 2010, 20(16), 4922-4926.
[9]
Kostova, I. Coumarins as inhibitors of HIV reverse transcriptase. Curr. HIV Res., 2006, 4(3), 347-363.
[10]
Chilin, A.; Battistutta, R.; Bortolato, A.; Cozza, G.; Zanatta, S.; Poletto, G.; Mazzorana, M.; Zagotto, G.; Uriarte, E.; Guiotto, A.; Pinna, L.A. Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure–activity relationships. J. Med. Chem., 2008, 51(4), 752-759.
[11]
Kurosu, H.; Maehama, T.; Okada, T.; Yamamoto, T.; Hoshino, S.I.; Fukui, Y.; Ui, M.; Hazeki, O.; Katada, T. Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110β is synergistically activated by the βγ subunits of G proteins and phosphotyrosyl peptide. J. Biol. Chem., 1997, 272(39), 24252-24256.
[12]
Roche, S.; Downward, J.; Raynal, P.; Courtneidge, S.A. A function for phosphatidylinositol 3-kinase β (p85α-p110β) in fibroblasts during mitogenesis: requirement for insulin-and lysophosphatidic acid-mediated signal transduction. Mol. Cell. Biol., 1998, 18(12), 7119-7129.
[13]
You, L.; Feng, S.; An, R.; Wang, X. Osthole: a promising lead compound for drug discovery from a traditional Chinese medicine (TCM). Nat. Prod. Commun., 2009, 4(2), 297-302.
[14]
Okamoto, T.; Kobayashi, T.; Yoshida, S. Chemical aspects of coumarin compounds for the prevention of hepatocellular carcinomas. Curr. Med. Chem. Anticancer Agents, 2005, 5(1), 47-51.
[15]
You, L.; An, R.; Wang, X.; Li, Y. Discovery of novel osthole derivatives as potential anti-breast cancer treatment. Bioorg. Med. Chem. Lett., 2010, 20(24), 7426-7428.
[16]
Tang, C.H.; Yang, R.S.; Chien, M.Y.; Chen, C.C.; Fu, W.M. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. Eur. J. Pharmacol., 2008, 579(1), 40-49.
[17]
Okamoto, T.; Kobayashi, T. Synthetic derivatives of osthole for the prevention of hepatitis. Med. Chem., 2007, 3(1), 35-44.
[18]
Shokoohinia, Y.; Jafari, F.; Mohammadi, Z.; Bazvandi, L.; Hosseinzadeh, L.; Chow, N.; Bhattacharyya, P.; Farzaei, M.H.; Farooqi, A.A.; Nabavi, S.M.; Yerer, M.B. Potential anticancer properties of osthol: A comprehensive mechanistic review. Nutrients, 2018, 10(1), 36.
[19]
Shokoohinia, Y.; Khajouei, S.; Ahmadi, F.; Ghiasvand, N.; Hosseinzadeh, L. Protective effect of bioactive compounds from Echinophora cinerea against cisplatin-induced oxidative stress and apoptosis in the PC12 cell line. Iran. J. Basic Med. Sci., 2017, 20(4), 438-445.
[20]
Kuo, P.L.; Hsu, Y.L.; Chang, C.H.; Chang, J.K. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells. J. Pharmacol. Exp. Ther., 2005, 314(3), 1290-1299.
[21]
Li, X.X.; Hara, I.; Matsumiya, T. Effects of osthole on postmenopausal osteoporosis using ovariectomized rats; comparison to the effects of estradiol. Biol. Pharm. Bull., 2002, 25(6), 738-742.
[22]
Hamelers, I.H.; Van Schaik, R.F.; Sussenbach, J.S.; Steenbergh, P.H. 17β-Estradiol responsiveness of MCF-7 laboratory strains is dependent on an autocrine signal activating the IGF type I receptor. Cancer Cell Int., 2003, 3(1), 10.
[23]
Zhang, L.; Jiang, G.; Yao, F.; He, Y.; Liang, G.; Zhang, Y.; Hu, B.; Wu, Y.; Li, Y.; Liu, H. Growth inhibition and apoptosis induced by osthole, a natural coumarin, in hepatocellular carcinoma. PLoS One, 2012, 7(5), e37865.
[24]
Xu, X.M.; Zhang, Y.; Qu, D.; Feng, X.W.; Chen, Y.; Zhao, L. Osthole suppresses migration and invasion of A549 human lung cancer cells through inhibition of matrix metalloproteinase-2 and matrix metallopeptidase-9 in vitro. Mol. Med. Rep., 2012, 6(5), 1018-1022.
[25]
Siskos, E.P.; Mazomenos, B.E.; Konstantopoulou, M.A. Isolation and identification of insecticidal components from Citrus aurantium fruit peel extract. J. Agric. Food Chem., 2008, 56(14), 5577-5581.
[26]
Rosselli, S.; Maggio, A.; Bellone, G.; Formisano, C.; Basile, A.; Cicala, C.; Alfieri, A.; Mascolo, N.; Bruno, M. Antibacterial and anticoagulant activities of coumarins isolated from the flowers of Magydaris tomentosa. Planta Med., 2007, 73(02), 116-120.
[27]
Okamoto, T.; Kobayashi, T. Synthetic derivatives of osthole for the prevention of hepatitis. Med. Chem., 2007, 3(1), 35-44.
[28]
Kawaii, S.; Tomono, Y.; Ogawa, K.; Sugiura, M.; Yano, M.; Yoshizawa, Y.; Ito, C.; Furukawa, H. Antiproliferative effect of isopentenylated coumarins on several cancer cell lines. Anticancer Res., 2000, 21(3B), 1905-1911.
[29]
Guo, Q.; Cao, H.; Qi, X.; Li, H.; Ye, P.; Wang, Z.; Wang, D.; Sun, M. Research Progress in reversal of tumor multi-drug resistance via natural products. Anticancer. Agents Med. Chem., 2017, 17(11), 1466-1476.
[30]
Chou, S.Y.; Hsu, C.S.; Wang, K.T.; Wang, M.C.; Wang, C.C. Antitumor effects of Osthol from Cnidium monnieri: an in vitro and in vivo study. Phytother. Res., 2007, 21(3), 226-230.
[31]
Yang, D.; Gu, T.; Wang, T.; Tang, Q.; Ma, C. Effects of osthole on migration and invasion in breast cancer cells. Biosci. Biotechnol. Biochem., 2010, 74(7), 1430-1434.
[32]
Farooq, S.; Hussain, A.; Hamid, A.; Qurishi, M.A.; Koul, S. Click chemistry inspired synthesis and bioevaluation of novel triazolyl derivatives of Osthol as potent cytotoxic agents. Eur. J. Med. Chem., 2014, 84, 545-554.
[33]
Tripathi, V.K.; Singh, J.; Ara, T.; Koul, S.; Farooq, S.; Kaul, A. Synthesis and biological evaluation of novel isoxazoles and triazoles linked 6-hydroxycoumarin as potent cytotoxic agents. Bioorg. Med. Chem. Lett., 2014, 24(17), 4243-4246.
[34]
Farooq, S.; Dangroo, N.A.; Priya, D.; Banday, J.A.; Sangwan, P.L.; Qurishi, M.A.; Koul, S.; Saxena, A.K. Isolation, cytotoxicity evaluation and HPLC-quantification of the chemical constituents from Prangos pabularia. PLoS One, 2014, 9(10), e108713.
[35]
Kostova, I.; Raleva, S.; Genova, P.; Argirova, R. Structure-activity relationships of synthetic coumarins as HIV-1 inhibitors. Bioinorg. Chem. Appl., 2006, 22, 274.
[36]
You, L.; Feng, S.; An, R.; Wang, X. Osthole: a promising lead compound for drug discovery from a traditional Chinese medicine (TCM). Nat. Prod. Commun., 2009, 4(2), 297-302.
[37]
Okamoto, T.; Kobayashi, T.; Yoshida, S. Chemical aspects of coumarin compounds for the prevention of hepatocellular carcinomas. Curr. Med. Chem. Anticancer Agents, 2005, 5(1), 47-51.
48
6